CHD7 Targets Active Gene Enhancer Elements to Modulate ES Cell-Specific Gene Expression

English version České info

CHD7 is one of nine members of the chromodomain helicase DNA–binding domain family of ATP–dependent chromatin remodeling enzymes found in mammalian cells. De novo mutation of CHD7 is a major cause of CHARGE syndrome, a genetic condition characterized by multiple congenital anomalies. To gain insights to the function of CHD7, we used the technique of chromatin immunoprecipitation followed by massively parallel DNA sequencing (ChIP–Seq) to map CHD7 sites in mouse ES cells. We identified 10,483 sites on chromatin bound by CHD7 at high confidence. Most of the CHD7 sites show features of gene enhancer elements. Specifically, CHD7 sites are predominantly located distal to transcription start sites, contain high levels of H3K4 mono-methylation, found within open chromatin that is hypersensitive to DNase I digestion, and correlate with ES cell-specific gene expression. Moreover, CHD7 co-localizes with P300, a known enhancer-binding protein and strong predictor of enhancer activity. Correlations with 18 other factors mapped by ChIP–seq in mouse ES cells indicate that CHD7 also co-localizes with ES cell master regulators OCT4, SOX2, and NANOG. Correlations between CHD7 sites and global gene expression profiles obtained from Chd7^+/+, Chd7^+/−, and Chd7^−/− ES cells indicate that CHD7 functions at enhancers as a transcriptional rheostat to modulate, or fine-tune the expression levels of ES–specific genes. CHD7 can modulate genes in either the positive or negative direction, although negative regulation appears to be the more direct effect of CHD7 binding. These data indicate that enhancer-binding proteins can limit gene expression and are not necessarily co-activators. Although ES cells are not likely to be affected in CHARGE syndrome, we propose that enhancer-mediated gene dysregulation contributes to disease pathogenesis and that the critical CHD7 target genes may be subject to positive or negative regulation.

Vyšlo v časopise: CHD7 Targets Active Gene Enhancer Elements to Modulate ES Cell-Specific Gene Expression. PLoS Genet 6(7): e32767. doi:10.1371/journal.pgen.1001023
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1001023

Souhrn

Zdroje

1. VissersLE

van RavenswaaijCM

AdmiraalR

HurstJA

de VriesBB

2004 Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 36 955 957

2. JongmansMC

van Ravenswaaij-ArtsCM

PitteloudN

OgataT

SatoN

2009 CHD7 mutations in patients initially diagnosed with Kallmann syndrome–the clinical overlap with CHARGE syndrome. Clin Genet 75 65 71

3. OgataT

FujiwaraI

OgawaE

SatoN

UdakaT

2006 Kallmann syndrome phenotype in a female patient with CHARGE syndrome and CHD7 mutation. Endocr J 53 741 743

4. KimH-G

KurthI

LanF

MelicianiI

WenzelW

2008 Mutations in CHD7, Encoding a Chromatin-Remodeling Protein, Cause Idiopathic Hypogonadotropic Hypogonadism and Kallmann Syndrome. Am J Hum Genet 83 511 519

5. GenneryAR

SlatterMA

RiceJ

HoefslootLH

BargeD

2008 Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome. Clin Exp Immunol 153 75 80

6. SankaM

TangsinmankongN

LoscalzoM

SleasmanJW

DorseyMJ

2007 Complete DiGeorge syndrome associated with CHD7 mutation. J Allergy Clin Immunol 120 952 954

7. LalaniSR

SafiullahAM

FernbachSD

HarutyunyanKG

ThallerC

2006 Spectrum of CHD7 Mutations in 110 Individuals with CHARGE Syndrome and Genotype-Phenotype Correlation. Am J Hum Genet 78 303 314

8. BosmanEA

PennAC

AmbroseJC

KettleboroughR

StempleDL

2005 Multiple mutations in mouse Chd7 provide models for CHARGE syndrome. Hum Mol Genet 14 3463 3476

9. SchnetzMP

BartelsCF

ShastriK

BalasubramanianD

ZentnerGE

2009 Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Res 19 590 601

10. HurdEA

CapersPL

BlauwkampMN

AdamsME

RaphaelY

2007 Loss of Chd7 function in gene-trapped reporter mice is embryonic lethal and associated with severe defects in multiple developing tissues. Mamm Genome 18 94 104

11. SanlavilleD

EtcheversHC

GonzalesM

MartinovicJ

Clement-ZizaM

2006 Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J Med Genet 43 211 317

12. HallJA

GeorgelPT

2007 CHD proteins: a diverse family with strong ties. Biochem Cell Biol 85 463 476

13. SrinivasanS

DorighiKM

TamkunJW

2008 Drosophila Kismet regulates histone H3 lysine 27 methylation and early elongation by RNA polymerase II. PLoS Genet 4 e1000217 10.1371/journal.pgen.1000217

14. SrinivasanS

ArmstrongJA

DeuringR

DahlsveenIK

McNeillH

2005 The Drosophila trithorax group protein Kismet facilitates an early step in transcriptional elongation by RNA Polymerase II. Development 132 1623 1635

15. FlanaganJF

MiLZ

ChruszczM

CymborowskiM

ClinesKL

2005 Double chromodomains cooperate to recognize the methylated histone H3 tail. Nature 438 1181 1185

16. HeintzmanND

HonGC

HawkinsRD

KheradpourP

StarkA

2009 Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459 108 112

17. HeintzmanND

StuartRK

HonG

FuY

ChingCW

2007 Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39 311 318

18. RobertsonG

HirstM

BainbridgeM

BilenkyM

ZhaoY

2007 Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 4 651 657

19. ViselA

BlowMJ

LiZ

ZhangT

AkiyamaJA

2009 ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457 854 858

20. CrawfordGE

DavisS

ScacheriPC

RenaudG

HalawiMJ

2006 DNase-chip: a high-resolution method to identify DNase I hypersensitive sites using tiled microarrays. Nat Methods 3 503 509

21. MeissnerA

MikkelsenTS

GuH

WernigM

HannaJ

2008 Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454 766 770

22. MikkelsenTS

KuM

JaffeDB

IssacB

LiebermanE

2007 Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448 553 560

23. ENCODE_ConsortiumT

2007 Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447 799 816

24. GuentherMG

LevineSS

BoyerLA

JaenischR

YoungRA

2007 A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130 77 88

25. BarskiA

CuddapahS

CuiK

RohTY

SchonesDE

2007 High-resolution profiling of histone methylations in the human genome. Cell 129 823 837

26. ChenX

XuH

YuanP

FangF

HussM

2008 Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133 1106 1117

27. HoL

JothiR

RonanJL

CuiK

ZhaoK

2009 An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci U S A 106 5187 5191

28. KuM

KocheRP

RheinbayE

MendenhallEM

EndohM

2008 Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet 4 e1000242 10.1371/journal.pgen.1000242

29. KimTH

AbdullaevZK

SmithAD

ChingKA

LoukinovDI

2007 Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell 128 1231 1245

30. SchugJ

SchullerWP

KappenC

SalbaumJM

BucanM

2005 Promoter features related to tissue specificity as measured by Shannon entropy. Genome Biol 6 R33

31. NiwaH

2007 How is pluripotency determined and maintained? Development 134 635 646

32. PereiraCF

TerranovaR

RyanNK

SantosJ

MorrisKJ

2008 Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2. PLoS Genet 4 e1000170 10.1371/journal.pgen.1000170

33. NicholsJ

ZevnikB

AnastassiadisK

NiwaH

Klewe-NebeniusD

1998 Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95 379 391

34. MasuiS

NakatakeY

ToyookaY

ShimosatoD

YagiR

2007 Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9 625 635

35. LimCY

TamWL

ZhangJ

AngHS

JiaH

2008 Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. Cell Stem Cell 3 543 554

36. HoL

RonanJL

WuJ

StaahlBT

ChenL

2009 An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc Natl Acad Sci U S A 106 5181 5186

37. MohrmannL

VerrijzerCP

2005 Composition and functional specificity of SWI2/SNF2 class chromatin remodeling complexes. Biochim Biophys Acta 1681 59 73

38. TrotterKW

ArcherTK

2008 The BRG1 transcriptional coregulator. Nucl Recept Signal 6 e004

39. BajpaiR

ChenDA

Rada-IglesiasA

ZhangJ

XiongY

CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature 463 958 962